Morton Coleman
Hematology & Oncology · New York, NYNPI 1851460406
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $57,865 of the $84,192 with a category attached, or 68.7%. 7 manufacturers reported payments, led by Pharmacyclics LLC, An Abbvie Company at 44.1% of the total. Reporting peaked in 2019 at $59,147 and has fallen 95.3% since, to $2,768 in 2023. Among hematology & oncology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 89 payments — averaging $945.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pharmacyclics LLC, An Abbvie Company$37K
- Gilead$19K
- Johnson & Johnson$15K
- Epizyme, Inc.$7K
- E.r. Squibb & Sons, L.L.C.$3K
- Bristol Myers Squibb$2K
- plus $19 from 1 others
Across 1,032 payments — averaging $7684.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Beigene, Ltd.$4.8M
- Bristol Myers Squibb$889K
- Acerta Pharma LLC$801K
- Incyte Corporation$444K
- Eli Lilly$217K
- Seagen Inc.$134K
- plus $599K from 25 others
What the payments were for
- Consulting fees$12,14414%
- Speaking & faculty fees$57,86569%
- Travel & lodging$12,72015%
- Food & beverage$1,3642%
- Education$990%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pharmacyclics LLC, An Abbvie Company | 39 | $37,160 |
| Gilead(2 entities) | 16 | $19,235 |
| Johnson & Johnson | 23 | $14,940 |
| Epizyme, Inc. | 5 | $7,428 |
| E.r. Squibb & Sons, L.L.C. | 3 | $3,460 |
| Bristol Myers Squibb | 2 | $1,949 |
| Amgen | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$84,192 in reported general payments places this provider in the 90th percentile of 967 hematology & oncology providers in New York.
Other hematology & oncology in New York
- Michael SchusterNew York$1.6M
- Charles SawyersNew York$1.6M
- Manuel Hidalgo-MedinaNew York$1.4M
- Ross LevineNew York$968K
- Joshua SabariNew York$761K
- Gail RobozNew York$738K
- Jeffrey LaurenceNew York$640K
- John AllanNew York$580K
- Ilan ShapiraNew York$475K
- John MascarenhasNew York$456K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.